Thank you, Mr. Speaker. Mr. Speaker, the Mifegymiso pill is actually something that is prescribed by physicians in the Northwest Territories, so it can be prescribed. I think the difficulty that we have is that it is not covered by all of our insurance programs or supplementary health programs that we have out there.

We know in the Northwest Territories there is a gap of individuals who are not covered by our supplemental health programs and do not have insurance from their employer. All other individuals can get this covered. In that light, we are conducting an internal review of the supplementary health benefits program, and that work is happening right now with the view of addressing the coverage gaps that exist that I think this particular pill falls under. We are hoping to get that review done so that we can have some informed discussions with Members and the public on how we can work together to close that gap and in an equitable, affordable, and fair way.